Factors beyond carbohydrates have a substantial influence on blood glucose levels meaning current automated insulin delivery systems miss vital information required for glucose regulation, a new study ...

Kurdikar, CEO of Embecta (EMBC) said, “As our stand-up work nears completion and following an in-depth review of our portfolio ...

CEO Dev Kurdikar said the decision may “come as a surprise” as Embecta just received FDA clearance for a patch pump, but the company “did not intend to do a full market launch of this product.” ...

Despite winning an FDA green light nearly three months ago for its first wearable insulin delivery system, Embecta is now ...

A new therapy for brittle type 1 diabetes, the only treatment currently approved by the U.S. Food and Drug Administration, is ...

The clearance paves the way for the launch of Medtronic’s Smart MDI system, which combines its InPen and Simplera continuous ...

So on that note, Ypsomed Holding (VTX:YPSN) looks quite promising in regards to its trends of return on capital. If you haven't worked with ROCE before, it measures the 'return' (pre-tax profit) a ...

has announced its donation of several insulin pumps to children with type 1 diabetes who are receiving treatment at the Diabetes Clinic in Salmaniya Medical Complex, part of the government hospitals.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Nov. 12, 2024 (GLOBE NEWSWIRE) -- The "Insulin Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path ...